HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 750329Generated: October 26, 2026
1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide → HCID 69156329, compound
https://huagongshe.com/reaction/750329
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 1-Ethyl-3-(3'-dimethylaminopropyl)carbodiimide | HCID 15908 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | 2-Benzoyl-4-bromobenzoic acid | HCID 346734 | — |
| Reactant | 4-[(2-hydroxybutylamino)methyl]benzenesulfonamide Hydrochloride | HCID 69156836 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Solvent | Triethylamine | HCID 8471 | — |
| Product | HCID 69156329 | HCID 69156329 | 17.8% |
Reaction Steps
To a solution of 4-[(2-hydroxybutylamino)methyl]benzenesulfonamide hydrochloride (842 mg) and 2-benzoyl-4-bromobenzoic acid (915 mg) and 1-hydroxy-1H-benzotriazole (643 mg) in DMF (20 ml) was added triethylamine (1.25 ml) and then WSC (1.03 g) was added at room temperature, and the mixture was stirred at room temperature for 15 hrs. The solvent was evaporated under reduced pressure, and the residue was partitioned between dichloromethane and water, washed with 1N hydrochloric acid, aqueous sodium hydrogen carbonate and brine and dried by adding sodium sulfate. The solvent was evaporated under reduced pressure and the obtained residue was purified by silica gel column chromatography (n-hexane/ethyl acetate=1/1→1/9). The obtained colorless amorphous form was dissolved in dichloromethane (20 ml) and 4-methylmorpholine N-oxide (612 mg) and molecular sieves 4A (500 mg) were added. Under ice-cooling, tetra-n-propylammonium perruthenate (31 mg) was added, and the mixture was stirred at room temperature for 3 hrs. The molecular sieves 4A was removed from the reaction solution by filtration. The solvent was evaporated under reduced pressure and the obtained residue was purified by silica gel column chromatography (n-hexane/ethyl acetate=7/3→1/1). The obtained colorless amorphous form was dissolved in ethanol (20 ml) and 1,8-diazabicyclo[5.4.0]-7-undecene (0.84 ml) was added. The mixture was heated under reflux for 12 hrs. The solvent was evaporated under reduced pressure, and the residue was partitioned between ethyl acetate and 1N hydrochloric acid, washed with aqueous sodium hydrogen carbonate and brine and sodium sulfate was added to dry the mixture. The solvent was evaporated under reduced pressure and the obtained residue was purified by silica gel column chromatography (n-hexane/ethyl acetate=7/3→1/1) to give the title compound (267 mg, 17%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07402595B2 |
|---|
| Source dataset | uspto-grants-2008_07 |
|---|
| ORD ID | ord-2dd8d029a50b43538e7533c345c479e4 |
|---|
| Source note | uspto-grants-2008_07 |
|---|